Figure 1 IFM 2010-02 flow diagram.... | American Society of Hematology

Figure 1. IFM 2010-02 flow diagram. *Toxicity related to study treatment. **Death not related to toxicity and progression. EE, efficacy evaluable.

Figure 1

IFM 2010-02 flow diagram. *Toxicity related to study treatment. **Death not related to toxicity and progression. EE, efficacy evaluable.

This Feature Is Available To Subscribers Only

Sign In or Create an Account